International Clinical Trial: IIIb confirmatory clinical study of boritinib in patients with locally advanced or metastatic non-small cell lung cancer with MET exon 14 mutation

Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115365) titled 'IIIb confirmatory clinical study of boritinib in patients with locally advanced or metastatic non-small cell lung cancer with MET exon 14 mutation' on Dec. 25, 2025.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Guangdong Provincial People's Hospital(Guangdong Academy of Medical Sciences)

Condition: metastatic non-small cell lung cancer with MET exon 14 mutation

Recruitment Status: Recruiting

Phase: 3

Date of First Enrollment: 2023-09-25

Target Sample Size: Monotherapy group:131;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html...